CaRISMA
Study point of contact
| Charles Jonassaint, PhD, MHS | |
| 412-586-9850 | |
| [email protected] |
Locations
1 United States site
Genotypes
All SCD
Study type
Digital
Gender
All
Interventions
c-CBT, m-Education
Compensation
Yes
About the study
To identify treatments that do not rely only on opioids or other medications. Participants will use their smartphone to answer questionnaires and interact with a mobile application.
participation requirements
- People with any type of sickle cell disease
- Male or female, age 18 years or older
- Reports chronic pain: i.e pain more days than not for the past 3 months or longer and/or is prescribed daily or long-acting opioids for pain.
- English speaking
participation restrictions
- Any potential participants who fail consent comprehension questions
Locations
- United States [Recruiting]